Saponin Extracts from Gynostemma Pentaphyllum (thunb.) Makino Display Sedative-Hypnotic and Anxiolytic Effects
Chun-Yan Shen,Pan-Yu Ma,Jing-Jing Zhu,Jian-Guo Jiang,Li Liu,Yan-Kui Yi,Hong-Xia Zhu,Qiang Liu
DOI: https://doi.org/10.1016/j.indcrop.2020.112893
IF: 6.449
2020-01-01
Industrial Crops and Products
Abstract:Gynostemma pentaphyllum (Thunb.) Makino (G. pentaphyllum) is widely consumed in China because of various beneficial effects. This present study aimed to explore the sleep-enhancing activities of G. pentaphyllum. In the present study, saponin-rich fractions of GPMB and GPMS were extracted from G. pentaphyllum. The sedative-hypnotic and anxiolytic functions in vivo were evaluated by behavioral tests and neuronal morphology changes. Levels of neurotransmitters, cytokines and hormone in the hypothalamus and hippocampus were investigated and compared. The data indicated that GPMS (67.5 %) contained higher saponin content than GPMB (40.7 %) Administration of GPMB and GPMS exhibited sedative and anxiolytic potential, as evidenced by the reduced immobility time in tail suspension test, shortened sleep latency, and prolonged sleep time in sodium pentobarbital-induced sleeping assay. P-chlorophenylalanine-induced histological injuries in brains were vividly recovered by GPMB and GPMS administration. Treatment of GPMB and GPMS also affected concentrations of 5-hydroxytryptamine (5-HT), dopamine (DA), noradrenaline (NE), glutamate (Glu), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and prostaglandin D-2 (PGD(2)) concentrations in plasma by regulating 5-hydroxytryptamine 1A (5-HT1A), 5-hydroxytryptamine 2A (5-HT2A), GABA(A) receptor alpha 2 (GABA(A)R alpha 2), GABA(A) receptor alpha 3 (GABA(A)R alpha 3), glutamic acid decarboxylase (GAD) 65/67, IL-6,TNF-alpha, and IL-1 beta expression in the hypothalamus and hippocampus. Interestingly, the potency and selectivity of GPMB and GPMS differed. Efficacy of GPMB was better than GPMS at stimulating 5-HT1A, 5-HT2A, and TNF-alpha expression, whereas GPMS was more powerful in increasing GABA(A)R alpha 2, GABA(A)R alpha 3, GAD 65/67, and IL-1 beta expression. The constituent difference of GPMB and GPMS might partially explain the bioactivity discrepancy. In conclusion, GPMB and GPMS probably exerted sleep-enhancing effects by regulating serotonergic, GABAergic, and immune systems.